Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-27

Clinical Trial Update: A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of NS2 for non-infectious anterior uveitis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NS2

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Non-infectious Anterior Uveitis | Phase 2 | Status: COMPLETED | Results posted: 2023-03-27